Literature DB >> 7813540

Megadose methylprednisolone treatment for malignant osteopetrosis.

E M van Lie Peters, D C Aronson, V Everts, L J Dooren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813540     DOI: 10.1007/bf01954503

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  High dose intravenous methylprednisolone in treatment of recessive osteopetrosis.

Authors:  S Ozsoylu
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

2.  Juvenile osteopetrosis: effects on blood and bone of prednisone and a low calcium, high phosphate diet.

Authors:  L M Dorantes; A M Mejia; S Dorantes
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

3.  The hematopoietic effects of prednisone therapy in four infants with osteopetrosis.

Authors:  J D Reeves; W E Huffer; C S August; W E Hathaway; M Koerper; C E Walters
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

4.  Failure of calcitriol treatment in a patient with malignant osteopetrosis.

Authors:  E M van Lie Peters; D C Aronson; V Everts; L J Dooren
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

5.  Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course.

Authors:  E J Gerritsen; J M Vossen; I H van Loo; J Hermans; M H Helfrich; C Griscelli; A Fischer
Journal:  Pediatrics       Date:  1994-02       Impact factor: 7.124

  5 in total
  3 in total

Review 1.  Autosomal recessive osteopetrosis: diagnosis, management, and outcome.

Authors:  C J Wilson; A Vellodi
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

2.  A newborn twin with unusual chest radiograph.

Authors:  B Thomas; A C Elias-Jones; A V Sridhar
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

3.  Osteopetrosis--improvement of hematologic findings with age.

Authors:  M Totan; D Albayrak
Journal:  Indian J Pediatr       Date:  1999 Sep-Oct       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.